---
title: Advancing Your Biologic Requires Bold Scientific Strategies
---

Advancing your biologic therapy through clinical development is a complex process. Learn about how we can make the impossible, possible...

| View in browser September 2023 Advancing Your Biologic Requires Bold Scientific Strategies    Advancing your biologic therapy through clinical development is a complex process full of challenges, requiring bold scientific strategies, operational proficiency, and the ability to navigate the regulatory requirements. Our global experts have successfully supported 250+ biologics projects and marketing applications in the past 3 years. As your full-service partner, Veristat is here to help you plan and launch your clinical trial and efficiently bring your biotherapeutic to its next development milestone. Read on to learn about how our teams have helped sponsors accelerate positive outcomes, resulting in less work for sponsors and more hope for patients.  Your Full-Service Partner for Biologics   Efficiently bring your biologic through the clinical development journey to approval and commercial success. From cell & gene therapies to mRNA vaccines to monoclonal antibodies and more, biologics require versatile planning and development. Veristat’s global team leverages lessons learned over the course of our work supporting 13 IND/CTAs and 8 marketing applications in the past 3 years. Find out more > Stay connected Connect with us to keep up with the latest news, case studies, guides, and events designed to help pharma and biotech companies stay on top of trends and challenges arising in clinical development, regulatory affairs, and commercialization. Case Study: Global Pediatric Full-Service Phase 1/2 Clinical Trial Begins on Heels of Successful Natural History Study A mid-size biotech company sought Veristat early in clinical development for help with a Natural History Trial. After its successful implementation, the sponsor moved forward with the novel gene therapy treatment program, which has already treated its first patients. Read how Veristat continues to provide full-service support for the Phase 1/2 clinical trial. Learn more > Case Study: Flexibility Drives Progress During a Rare Disease Gene Therapy Clinical Trial Veristat was engaged by a biotech organization focusing on gene therapies for metabolic diseases to support their clinical study for the treatment of a rare human genetic lysosomal storage disorder. Through a collaborative partnership and a flexible operating model, our experts addressed clinical operations challenges to satisfy our sponsor's requirements at every milestone. Learn more >  Case Study: Study Collaboration for Successful COVID-19 Vaccine Program Advance your vaccine through the regulatory hurdles, recruitment challenges, and approval process to safely bring vaccines to market. Learn how Veristat supported HIPRA, a European multinational pharmaceutical company, with several international studies to test the efficacy, tolerability, and safety of its RBD dimer recombinant protein vaccine, branded as BIMERVAX®, against SARS-CoV-2. Learn more >   Upcoming Events/Webinars Event: BIOSPAIN 2023 September 26  \|  Barcelona, Spain Event: Medtech & Pharma Platform (MPP) Conference 2023 September 27  \|  Basel, Switzerland CONTACT US VERISTAT.COM Veristat, 134 Turnpike Road, Suite 200, Southborough, MA 01772 Manage preferences |
| --- |